Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2,666,933
-
Total 13F shares
-
215,532
-
Share change
-
+37,149
-
Total reported value
-
$409,125
-
Price per share
-
$1.87
-
Number of holders
-
7
-
Value change
-
+$72,340
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) as of Q3 2024
As of 30 Sep 2024 LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 215,532 shares of stock of the company.
Largest 7 holders included HighTower Advisors, LLC, FNY Investment Advisers, LLC, Ethos Financial Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), UBS Group AG, and BANK OF AMERICA CORP /DE/.
This table shows 7 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.